Literature DB >> 338406

Inhibition of glucagon release by serotonin in mouse pancreatic islets.

J Marco, J A Hedo, M L Villanueva.   

Abstract

In this work we have investigated the effect of serotonin on glucagon release in mouse pancreatic islets isolated by the collagenase technique. Incubation of the islets with serotonin (4 X10(-3)mol/l) was associated with an inhibition of glucagon output both in the basal medium (3.3 mmol/l glucose) and in the presence of arginine (10 mmol/l). The inhibitory effect of serotonin on basal glucagon release was also apparent at concentrations of 2 X10(-3) mol/l, 10(-3)mol/l and 5 X 10(-4) mol/l. Addition of 5-hydroxytrypophan (4 X10(-3) mol/l) to the incubation medium was without effect on basal glucagon output while it significantly reduced arginine-induced glucagon release. In contrast, tryptophan (4 X10(-3) mol/l) provoked glucagon secretion. As inferred from our previous human studies, the present data indicate that serotonin is able to inhibit glucagon secretion. These findings provide further support for the participation of a serotoninergic mechanism in the control of A-cell function.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 338406     DOI: 10.1007/bf01236311

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  15 in total

1.  Amino acid conversion into 5-hydroxytryptamine in pancreatic beta-cells.

Authors:  E Gylfe; B Hellman; J Sehlin; I B Taljedal
Journal:  Endocrinology       Date:  1973-10       Impact factor: 4.736

2.  Insulin release by isolated pancreatic islets of the mouse incubated in vitro.

Authors:  E Coll-Garcia; J R Gill
Journal:  Diabetologia       Date:  1969-04       Impact factor: 10.122

3.  Serotonin inhibition of in vitro insulin release from golden hamster pancreas.

Authors:  J M Feldman; H E Lebovitz
Journal:  Endocrinology       Date:  1970-01       Impact factor: 4.736

4.  Potentiation of insulin secretion in vitro by serotonin antagonists.

Authors:  J M Feldman; K E Quickel; H E Lebovitz
Journal:  Diabetes       Date:  1972-07       Impact factor: 9.461

5.  Catechol- and indolamines in some endocrine cell systems. An autoradiographical, histochemical and radioimmunological study.

Authors:  H Tjälve
Journal:  Acta Physiol Scand Suppl       Date:  1971

6.  Method for the isolation of intact islets of Langerhans from the rat pancreas.

Authors:  P E Lacy; M Kostianovsky
Journal:  Diabetes       Date:  1967-01       Impact factor: 9.461

7.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

8.  The significance of 5-hydroxytryptamine for insulin secretion in the mouse.

Authors:  A Lernmark
Journal:  Horm Metab Res       Date:  1971-09       Impact factor: 2.936

9.  Glucagon-stimulating activity of 20 amino acids in dogs.

Authors:  D M Rocha; G R Faloona; R H Unger
Journal:  J Clin Invest       Date:  1972-09       Impact factor: 14.808

10.  Potentiation of glucagon secretion by serotonin antagonists in man.

Authors:  J Marco; J A Hedo; J Martinell; C Calle; M L Villanueva
Journal:  J Clin Endocrinol Metab       Date:  1976-02       Impact factor: 5.958

View more
  10 in total

1.  Human Beta Cells Produce and Release Serotonin to Inhibit Glucagon Secretion from Alpha Cells.

Authors:  Joana Almaça; Judith Molina; Danusa Menegaz; Alexey N Pronin; Alejandro Tamayo; Vladlen Slepak; Per-Olof Berggren; Alejandro Caicedo
Journal:  Cell Rep       Date:  2016-12-20       Impact factor: 9.423

2.  Role of Serotonin (5-HT) in GDM Prediction Considering Islet and Liver Interplay in Prediabetic Mice during Gestation.

Authors:  Melissa Asuaje Pfeifer; Moritz Liebmann; Till Beuerle; Katharina Grupe; Stephan Scherneck
Journal:  Int J Mol Sci       Date:  2022-06-09       Impact factor: 6.208

3.  Design, Synthesis, and Characterization of a Novel Fluoroprobe for Live Human Islet Cell Imaging of Serotonin 5-HT1A Receptor.

Authors:  Robert W Garvey; Enza Lacivita; Mauro Niso; Beata Duszyńska; Paul E Harris; Marcello Leopoldo
Journal:  ChemMedChem       Date:  2022-04-05       Impact factor: 3.540

4.  Improved oral glucose tolerance following antiserotonin treatment in patients with chemical diabetes.

Authors:  C Ferrari; C Barbieri; R Caldara; V Magnoni; G P Testori; M Romussi
Journal:  Eur J Clin Pharmacol       Date:  1979-07       Impact factor: 2.953

Review 5.  Prostaglandins and serotonin: nonpeptide diarrheogenic hormones.

Authors:  B M Jaffe
Journal:  World J Surg       Date:  1979-09-20       Impact factor: 3.352

6.  Possible role of glucagon in cyproheptadine-induced increase of insulin secretion.

Authors:  A Pezzarossa; V Coiro; U Butturini
Journal:  Acta Diabetol Lat       Date:  1982 Jul-Sep

7.  Biogenic amine regulation of glucagon secretion.

Authors:  P Matsumoto; A Brown; J C Dunbar
Journal:  Acta Diabetol Lat       Date:  1984 Oct-Dec

8.  Targeting the Pancreatic α-Cell to Prevent Hypoglycemia in Type 1 Diabetes.

Authors:  Julia K Panzer; Alejandro Caicedo
Journal:  Diabetes       Date:  2021-12       Impact factor: 9.461

9.  Intercellular Communication in the Islet of Langerhans in Health and Disease.

Authors:  Xue W Ng; Yong H Chung; David W Piston
Journal:  Compr Physiol       Date:  2021-06-30       Impact factor: 8.915

Review 10.  Serotonergic Control of Metabolic Homeostasis.

Authors:  Steven C Wyler; Caleb C Lord; Syann Lee; Joel K Elmquist; Chen Liu
Journal:  Front Cell Neurosci       Date:  2017-09-20       Impact factor: 5.505

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.